People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Reneo Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $159.4M | $519.8M | 2024 |
| Mirum Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $138.5M | $348.3M | 2020 |
| Rhythm Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $60.5M | $696.2M | 2015 |
Edward T. Mathers at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Edward T. Mathers on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ed Mathers | 2 | 11 |
| Michael Grey | 2 | 10 |
| Michael G. Grey | 2 | 2 |
| Patrick Heron | 1 | 11 |
| Jonathan Leff | 1 | 11 |
| Tiba Aynechi | 1 | 9 |
| Niall O'Donnell | 1 | 7 |
| Patrick J. Heron | 1 | 7 |
| NEIL EXTER | 1 | 5 |
| Scott Weiner | 1 | 4 |
| Keith Gottesdiener | 1 | 4 |
| Kenneth Harrison | 1 | 4 |
| Susan Dube | 1 | 3 |
| Jonathan T. Silverstein | 1 | 3 |
| Art Pappas | 1 | 3 |
| Laura Brege | 1 | 3 |
| Bali Muralidhar | 1 | 3 |
| David P. Meeker, M.D. | 1 | 2 |
| Todd T. Foley | 1 | 2 |
| William C. Fairey | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.